Oncology Analytics Raises $21 Million in Series B

Oncology Analytics, a leading technology-enabled service company providing health plans, providers, and patients with an evidence-based, analytics-focused approach to utilization management for oncology, completed an oversubscribed Series B funding round of $21 million. Oak HC/FT led the round and was joined by new investor McKesson Ventures, along with returning investors Blue Cross Blue Shield Venture Partners and Sandbox Advantage Fund.

Oncology Analytics plans to use the funds to expand its oncology benefits management capabilities and accelerate strategic investments in data analytics, data science, and innovative digital health technologies.